AVENUE THERAPEUTICS, INC. (ATXI)

Latest Insider Confidence Score

2026Q1

50.0
Bearish

Company insider confidence (by quarter)

2017Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Lu Lucy — 748,949 Dec 20, 2021
Rosenwald Lindsay A Md Director 354,318 Sep 12, 2023
Fortress Biotech, Inc. — 328,524 Apr 2, 2025
MacLean Alexandra — 170,000 Sep 25, 2024
Vazzano Joseph Walter CFO 165,757 Dec 20, 2021

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 2, 2026 Jan 6, 2026 Fortress Biotech, Inc. 10% Owner Neutral 90.0 +111,209 33.85% ✗ -
Mar 31, 2025 Apr 2, 2025 Fortress Biotech, Inc. 10% Owner Neutral 90.0 +33,724 11.44% ✗ -
Jan 3, 2025 Fortress Biotech, Inc. 10% Owner Neutral 52.5 - 0.00% ✗ -
Dec 2, 2024 Dec 3, 2024 Herskowitz Neil Director Sell 27.5 -23 -19.17% ✗ $46
Nov 5, 2024 Nov 7, 2024 KRANZLER JAY D Director Sell 27.5 -61 -9.84% ✗ $136.6
Sep 27, 2024 Oct 1, 2024 KRANZLER JAY D Director Buy 90.0 +500 416.67% ✗ $1.2K
Sep 23, 2024 Sep 25, 2024 ROSENWALD LINDSAY A MD Director Neutral 52.5 - 0.00% ✗ -
Sep 23, 2024 Sep 25, 2024 Herskowitz Neil Director Neutral 52.5 - 0.00% ✗ -
Sep 23, 2024 Sep 25, 2024 Oltmans Curtis Gale Director Neutral 52.5 - 0.00% ✗ -
Sep 23, 2024 Sep 25, 2024 MacLean Alexandra CEO Neutral 90.0 +170,000 100.00% ✗ -
Sep 23, 2024 Sep 25, 2024 KRANZLER JAY D Director Neutral 52.5 - 0.00% ✗ -
Sep 23, 2024 Sep 25, 2024 Jin David COO Neutral 90.0 +65,000 100.00% ✗ -
Sep 23, 2024 Sep 25, 2024 Charles Faith L. Director Neutral 52.5 - 0.00% ✗ -
Dec 11, 2023 Dec 13, 2023 Davidow Robert L 10% Owner Sell 22.5 -617,000 -33.59% ✗ $86.6K
Nov 28, 2023 Davidow Robert L 10% Owner Neutral 52.5 - 0.00% ✗ -
Sep 8, 2023 Sep 12, 2023 ROSENWALD LINDSAY A MD Director Buy 97.5 +348,675 6178.89% ✗ $251K
Jun 30, 2023 Jul 5, 2023 Charles Faith L. Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2023 Jul 5, 2023 Jin David COO Neutral 52.5 - 0.00% ✗ -
Jun 30, 2023 Jul 5, 2023 ROSENWALD LINDSAY A MD Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2023 Jul 5, 2023 KRANZLER JAY D Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2023 Jul 5, 2023 Oltmans Curtis Gale Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2023 Jul 5, 2023 Herskowitz Neil Director Neutral 52.5 - 0.00% ✗ -
Jun 29, 2023 Jul 3, 2023 MacLean Alexandra CEO Neutral 52.5 - 0.00% ✗ -
Oct 11, 2022 Oct 13, 2022 InvaGen Pharmaceuticals, Inc. 10% Owner Sell 17.5 -388,888 -100.00% ✗ $3M
Aug 3, 2022 MacLean Alexandra CEO Neutral 52.5 - 0.00% ✗ -
May 25, 2022 Jin David COO Neutral 52.5 - 0.00% ✗ -
May 17, 2022 Charles Faith L. Director Neutral 52.5 - 0.00% ✗ -
Dec 17, 2021 Dec 21, 2021 KRANZLER JAY D Director Neutral 90.0 +69,020 106.74% ✗ -
Dec 17, 2021 Dec 21, 2021 Herskowitz Neil Director Neutral 90.0 +69,020 60.16% ✗ -
Dec 17, 2021 Dec 21, 2021 Oltmans Curtis Gale Director Neutral 90.0 +49,020 100.00% ✗ -
Dec 21, 2021 Oltmans Curtis Gale Director Neutral 52.5 - 0.00% ✗ -
Dec 17, 2021 Dec 20, 2021 Lu Lucy CEO Neutral 90.0 +411,616 122.02% ✗ -
Dec 17, 2021 Dec 20, 2021 Vazzano Joseph Walter CFO Neutral 90.0 +100,505 154.03% ✗ -
Sep 15, 2021 Sep 15, 2021 Vazzano Joseph Walter CFO Sell 46.3 -7,160 -9.89% ✗ $11.6K
May 6, 2021 May 7, 2021 Herskowitz Neil Director Buy 77.5 +2,500 1.89% ✗ $10K
Aug 20, 2020 Aug 21, 2020 Vazzano Joseph Walter CFO Sell 46.3 -3,840 -6.27% ✗ $46.6K
Jun 16, 2020 Jun 16, 2020 KRANZLER JAY D Director Neutral 90.0 +10,000 13.39% ✗ -
Jun 16, 2020 Jun 16, 2020 Herskowitz Neil Director Neutral 85.0 +10,000 8.18% ✗ -
Mar 9, 2020 Mar 10, 2020 Vazzano Joseph Walter CFO Buy 86.3 +3,389 5.86% ✗ $27K
Feb 26, 2020 Mar 2, 2020 Herskowitz Neil Director Buy 78.8 +2,561 2.14% ✗ $21.1K
Feb 25, 2020 Feb 25, 2020 Vazzano Joseph Walter CFO Buy 78.8 +1,200 2.12% ✗ $10.9K
Feb 25, 2020 Feb 25, 2020 Herskowitz Neil Director Buy 90.0 +10,000 9.12% ✗ $93.1K
Feb 12, 2020 Feb 13, 2020 Vazzano Joseph Walter CFO Neutral 52.5 - 0.00% ✗ -
Feb 12, 2020 Feb 13, 2020 Lu Lucy CEO Neutral 52.5 - 0.00% ✗ -
Dec 31, 2019 InvaGen Pharmaceuticals, Inc. 10% Owner Neutral 52.5 - 0.00% ✗ -
Sep 12, 2019 Sep 16, 2019 Ingram Elizabeth Garrett Director Buy 95.0 +16,000 100.00% ✗ $100.3K
Aug 27, 2019 Aug 28, 2019 KRANZLER JAY D Director Neutral 90.0 +10,000 15.46% ✗ -
Aug 27, 2019 Aug 28, 2019 Herskowitz Neil Director Neutral 90.0 +10,000 10.03% ✗ -
Aug 8, 2019 Aug 12, 2019 Vazzano Joseph Walter CFO Sell 46.3 -4,688 -7.64% ✗ $26.2K
Aug 1, 2019 Ingram Elizabeth Garrett Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2019 Jun 19, 2019 Herskowitz Neil Director Buy 86.3 +5,000 5.28% ✗ $29.3K
Jun 3, 2019 Jun 5, 2019 Vazzano Joseph Walter CFO Neutral 52.5 - 0.00% ✗ -
Jun 3, 2019 Jun 5, 2019 Lu Lucy CEO Neutral 52.5 - 0.00% ✗ -
Apr 30, 2019 Moore Thomas Gregory Director Neutral 52.5 - 0.00% ✗ -
Apr 15, 2019 Apr 15, 2019 Herskowitz Neil Director Buy 77.5 +1,000 1.07% ✗ $4.5K
Mar 28, 2019 Mar 29, 2019 Herskowitz Neil Director Buy 78.8 +2,000 2.18% ✗ $10.2K
Feb 25, 2019 Feb 25, 2019 Herskowitz Neil Director Buy 86.3 +5,000 5.77% ✗ $27.3K
Feb 15, 2019 Gogtay Jaideep Ashok Director Neutral 52.5 - 0.00% ✗ -
Feb 15, 2019 Saxena Nishant Director Neutral 52.5 - 0.00% ✗ -
Feb 4, 2019 Feb 6, 2019 Herskowitz Neil Director Buy 95.0 +8,850 11.37% ✗ $52K
Jan 30, 2019 Feb 1, 2019 Herskowitz Neil Director Buy 67.5 +650 0.84% ✗ $3.8K
Jan 28, 2019 Jan 30, 2019 Herskowitz Neil Director Buy 95.0 +10,000 14.89% ✗ $59K
Dec 3, 2018 Dec 12, 2018 Paley Jeffrey Director Buy 95.0 +15,000 23.20% ✗ $78.6K
Aug 7, 2018 Aug 8, 2018 Vazzano Joseph Walter VP Finance & Corp. Controller Neutral 90.0 +30,000 95.69% ✗ -
Aug 7, 2018 Aug 8, 2018 Lu Lucy CEO Neutral 90.0 +250,000 44.86% ✗ -
Aug 7, 2018 Aug 8, 2018 ROSENWALD LINDSAY A MD Director Neutral 90.0 +14,663 20.95% ✗ -
Aug 7, 2018 Aug 8, 2018 Herskowitz Neil Director Neutral 90.0 +14,663 27.93% ✗ -
Aug 7, 2018 Aug 8, 2018 KRANZLER JAY D Director Neutral 90.0 +14,663 29.33% ✗ -
Aug 7, 2018 Aug 8, 2018 Reines Scott Interim Chief Medical Officer Neutral 90.0 +10,000 28.57% ✗ -
Aug 7, 2018 Aug 8, 2018 WEISS MICHAEL S Director Neutral 90.0 +14,663 146.63% ✗ -
Aug 7, 2018 Aug 8, 2018 Paley Jeffrey Director Neutral 90.0 +14,663 29.33% ✗ -
Aug 7, 2018 Aug 8, 2018 SAMAD AKHTAR Director Neutral 90.0 +14,663 29.33% ✗ -
Jun 28, 2018 Jun 28, 2018 Vazzano Joseph Walter VP Finance & Corp. Controller Neutral 82.5 +1,351 4.50% ✗ -
Jun 14, 2018 Jun 15, 2018 Lu Lucy CEO Neutral 67.5 +5,000 0.91% ✗ -
Jun 1, 2018 Jun 12, 2018 ROSENWALD LINDSAY A MD Director Buy 95.0 +50,000 250.00% ✗ $214.1K
Jun 8, 2018 Jun 11, 2018 ROSENWALD LINDSAY A MD Director Buy 91.3 +5,234 26.17% ✗ $22.7K
Apr 25, 2018 Apr 25, 2018 Herskowitz Neil Director Buy 77.5 +1,000 1.94% ✗ $3.8K
Oct 17, 2017 Oct 18, 2017 Herskowitz Neil Director Buy 77.5 +1,000 1.98% ✗ $5K
Oct 4, 2017 Oct 10, 2017 ROSENWALD LINDSAY A MD Director Buy 95.0 +10,000 100.00% ✗ $55.8K
Oct 9, 2017 Oct 10, 2017 Herskowitz Neil Director Buy 77.5 +500 1.00% ✗ $2.6K
Sep 28, 2017 Oct 2, 2017 Lu Lucy CEO Neutral 67.5 +4,000 0.73% ✗ -
Sep 11, 2017 KRANZLER JAY D Director Neutral 52.5 - 0.00% ✗ -
Sep 6, 2017 Reines Scott Interim Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Aug 22, 2017 Vazzano Joseph Walter VP Finance & Corp. Controller Neutral 52.5 - 0.00% ✗ -
Aug 18, 2017 Herskowitz Neil Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2017 WEISS MICHAEL S Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2017 Lu Lucy CEO Neutral 52.5 - 0.00% ✗ -
Aug 18, 2017 ROSENWALD LINDSAY A MD Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2017 Paley Jeffrey Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2017 SAMAD AKHTAR Director Neutral 52.5 - 0.00% ✗ -